hydroxyindoleacetic acid has been researched along with DDPAC in 2 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kurihara, M | 2 |
Komatsu, H | 2 |
Sengoku, R | 2 |
Shibukawa, M | 2 |
Morimoto, S | 2 |
Matsubara, T | 2 |
Arakawa, A | 2 |
Orita, M | 2 |
Ishibashi, K | 2 |
Mitsutake, A | 2 |
Shibata, S | 2 |
Ishiura, H | 2 |
Adachi, K | 2 |
Ohse, K | 2 |
Hatano, K | 2 |
Ihara, R | 2 |
Higashihara, M | 2 |
Nishina, Y | 2 |
Tokumaru, AM | 2 |
Ishii, K | 2 |
Saito, Y | 2 |
Murayama, S | 2 |
Kanemaru, K | 2 |
Iwata, A | 2 |
Vermeiren, Y | 1 |
Janssens, J | 1 |
Aerts, T | 1 |
Martin, JJ | 1 |
Sieben, A | 1 |
Van Dam, D | 1 |
De Deyn, PP | 1 |
2 other studies available for hydroxyindoleacetic acid and DDPAC
Article | Year |
---|---|
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Frontotemporal Dementia; Humans; Hydroxyindole | 2023 |
Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
Topics: Aged; Alzheimer Disease; Brain; Dopamine; Female; Frontotemporal Dementia; Humans; Hydroxyindoleacet | 2016 |